How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

    The content on this page is not current guidance and is only for the purposes of the consultation process.

    Interventional procedure overview of epidermal radiotherapy using rhenium-188 paste for non-melanoma skin cancer

    Closed for comments This consultation ended on at   Request commenting lead permission

    References

    1. Castellucci P, Savoia F, Farina A et al. (2021). High dose brachytherapy with non sealed 188Re (rhenium) resin in patients with non-melanoma skin cancers (NMSCs): single center preliminary results. European Journal of Nuclear Medicine and Molecular Imaging, 48, 1511-1521.

    2. Sedda AF, Rossi G, Cipriani C et al. (2008). Dermatological high-dose-rate brachytherapy for the treatment of basal and squamous cell carcinoma. Clinical and Experimental Dermatology, 33(6), 745-9.

    3. Cipriani C, Desantis M, Dahlhoff G et al. (2022). Personalized irradiation therapy for NMSC by rhenium-188 skin cancer therapy: a long term retrospective study. Journal of Dermatological Treatment, 33(2), 969-975.

    4. Cipriani C, Frisch B, Scheidhauer Ket al. (2017). Personalized High-Dose-Rate Brachytherapy with Non-Sealed Rhenium-188 in Non-Melanoma Skin Cancer. International Journal of Nuclear Medicine Research, 114-122.

    5. Carrozzo AM, Sedda AF, Muscardin Let al. (2013). Dermo beta brachytherapy with188-Re in squamous cell carcinoma of the penis: a new therapy. European Journal of Dermatology, 23(2), 183–188.

    6. Carrozzo AM, Cipriani C, Donati Pet al. (2014). Dermo beta brachytherapy with 188Re in extramammary Paget's disease. Giornale Italiano di Dermatologia e Venereologia, 149(1):115-21.

    7. Schwarzenbock S, Kronert M, Kurth Jet al. (2022). Rhenium-188 as irradiation therapy for non-melanoma skin cancer- Study update. Eur J Nucl Med Mol Imaging, 49 (Supplement 1),S370.